Literature DB >> 32282904

Effect of 2'-5'/3'-5' phosphodiester linkage heterogeneity on RNA interference.

Maryam Habibian1, S Harikrishna2, Johans Fakhoury1, Maria Barton3, Eman A Ageely4, Regina Cencic5, Hassan H Fakih1, Adam Katolik1, Mayumi Takahashi6, John Rossi6, Jerry Pelletier5, Keith T Gagnon3,4, P I Pradeepkumar2, Masad J Damha1.   

Abstract

We report on the synthesis of siRNAs containing both 2'-5'- and 3'-5'-internucleotide linkages and their effects on siRNA structure, function, and interaction with RNAi proteins. Screening of these siRNAs against their corresponding mRNA targets showed that 2'-5' linkages were well tolerated in the sense strand, but only at a few positions in the antisense strand. Extensive modification of the antisense strand minimally affected 5'-phosphorylation of the siRNA by kinases, however, it negatively affected siRNA loading into human AGO2. Modelling and molecular dynamics simulations were fully consistent with these findings. Furthermore, our studies indicated that the presence of a single 5'p-rN1-(2'-5')-N2 unit in the antisense strand does not alter the 'clover leaf' bend and sugar puckers that are critical for anchoring the 5'-phosphate to Ago 2 MID domain. Importantly, 2'-5'-linkages had the added benefit of abrogating immune-stimulatory activity of siRNAs. Together, these results demonstrate that 2'-5'/3'-5'-modified siRNAs, when properly designed, can offer an efficient new class of siRNAs with diminished immune-stimulatory responses.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2020        PMID: 32282904      PMCID: PMC7229817          DOI: 10.1093/nar/gkaa222

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  52 in total

1.  Functional siRNAs and miRNAs exhibit strand bias.

Authors:  Anastasia Khvorova; Angela Reynolds; Sumedha D Jayasena
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

Review 2.  Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.

Authors:  Siddharth Shukla; Chintan S Sumaria; P I Pradeepkumar
Journal:  ChemMedChem       Date:  2010-03-01       Impact factor: 3.466

3.  RNA evolution and the origins of life.

Authors:  G F Joyce
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

4.  Re-Engineering RNA Molecules into Therapeutic Agents.

Authors:  Martin Egli; Muthiah Manoharan
Journal:  Acc Chem Res       Date:  2019-03-26       Impact factor: 22.384

5.  Oligoribonucleotides containing 2',5'-phosphodiester linkages exhibit binding selectivity for 3',5'-RNA over 3',5'-ssDNA.

Authors:  P A Giannaris; M J Damha
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

6.  DNA nanostructure serum stability: greater than the sum of its parts.

Authors:  Justin W Conway; Christopher K McLaughlin; Katherine J Castor; Hanadi Sleiman
Journal:  Chem Commun (Camb)       Date:  2013-02-11       Impact factor: 6.222

7.  Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs.

Authors:  Hartmut Jahns; Martina Roos; Jochen Imig; Fabienne Baumann; Yuluan Wang; Ryan Gilmour; Jonathan Hall
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

8.  RNAi factors are present and active in human cell nuclei.

Authors:  Keith T Gagnon; Liande Li; Yongjun Chu; Bethany A Janowski; David R Corey
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

9.  Structural insights into RNA duplexes with multiple 2΄-5΄-linkages.

Authors:  Fusheng Shen; Zhipu Luo; Hehua Liu; Rui Wang; Shenglong Zhang; Jianhua Gan; Jia Sheng
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

Review 10.  Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.

Authors:  Xiulong Shen; David R Corey
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

View more
  7 in total

1.  Hybrid DNA/RNA nanostructures with 2'-5' linkages.

Authors:  Arun Richard Chandrasekaran; Johnsi Mathivanan; Parisa Ebrahimi; Javier Vilcapoma; Alan A Chen; Ken Halvorsen; Jia Sheng
Journal:  Nanoscale       Date:  2020-11-05       Impact factor: 7.790

2.  From bench to bedside: Improving the clinical safety of GalNAc-siRNA conjugates using seed-pairing destabilization.

Authors:  Mark K Schlegel; Maja M Janas; Yongfeng Jiang; Joseph D Barry; Wendell Davis; Saket Agarwal; Daniel Berman; Christopher R Brown; Adam Castoreno; Sarah LeBlanc; Abigail Liebow; Tara Mayo; Stuart Milstein; Tuyen Nguyen; Svetlana Shulga-Morskaya; Sarah Hyde; Sally Schofield; John Szeto; Lauren Blair Woods; Vedat O Yilmaz; Muthiah Manoharan; Martin Egli; Klaus Charissé; Laura Sepp-Lorenzino; Patrick Haslett; Kevin Fitzgerald; Vasant Jadhav; Martin A Maier
Journal:  Nucleic Acids Res       Date:  2022-06-23       Impact factor: 19.160

3.  Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles.

Authors:  Sunit Jana; Leonora Abdullahu; Eman A Ageely; Ramadevi Chilamkurthy; Daniel O'Reilly; Philip J Jensik; Masad J Damha; Keith T Gagnon
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

Review 4.  Chemical strategies for strand selection in short-interfering RNAs.

Authors:  Andrew J Varley; Jean-Paul Desaulniers
Journal:  RSC Adv       Date:  2021-01-11       Impact factor: 3.361

Review 5.  Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.

Authors:  Yulin Fan; Zhijun Yang
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

Review 6.  Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry.

Authors:  Dagmara Baraniak; Jerzy Boryski
Journal:  Biomedicines       Date:  2021-05-31

7.  Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense Oligonucleotides.

Authors:  Thazha P Prakash; Jinghua Yu; Wen Shen; Cheryl Li De Hoyos; Andres Berdeja; Hans Gaus; Xue-Hai Liang; Stanley T Crooke; Punit P Seth
Journal:  ACS Med Chem Lett       Date:  2021-04-05       Impact factor: 4.632

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.